Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-20-004969)

Filing Details

Accession Number:: 0001127602-20-004969
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-11 19:02:21
Reporting Period:: 2020-02-10

Accepted Time:: 2020-02-11 19:02:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882095	Gilead Sciences Inc	GILD	Biological Products, (No Disgnostic Substances) (2836)	943047598

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198227	E Gayle Wilson	Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-10	21,720	$19.63	148,502	No	4	M	Direct
Common Stock	Disposition	2020-02-10	21,720	$67.72	126,782	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2020-02-10	21,720	$0.00	21,720	$19.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-05-11	No	4	M	Direct

Footnotes

Sale prices reported for the transactions reported here range from $67.71 to $67.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
The options vesed quarterly over the first year of service and were fully vested on May 11, 2011.